Literature DB >> 26195274

Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance.

James H Ho1,2, George P Bailey1,2, John R H Archer1, Paul I Dargan1,3, David M Wood4,5.   

Abstract

PURPOSE: Ethylphenidate is a novel psychoactive substance that is an analogue of methylphenidate. This paper describes its availability, patterns of use, and acute effects.
METHODS: Searches of the scientific and grey literature (publicly accessible Internet resources) were undertaken, using the keywords "Ethylphenidate", "Ethyl phenidate", "Ethyl phenyl(piperidin-2-yl)acetate", and "Nopaine", to identify information on the prevalence and patterns of use, desired effects, and toxicity of ethylphenidate. An Internet snapshot survey was performed on 10 February 2015 to provide information on availability and cost of ethylphenidate.
RESULTS: The literature search identified 1 case series of acute recreational ethylphenidate toxicity, 1 case report of ethylphenidate dependence, 1 qualitative analysis of user reports on Internet drug forums, 2 conference abstracts for surveillance studies, 1 report of two cases of ethylphenidate detected in post-mortem analyses, and 198 user reports on Internet discussion forums and social media sites. The Internet snapshot survey found 83 websites selling ethylphenidate, with purchase prices ranging from £28.20 ± 0.63 (€37.71 ± 0.85) per gram for a 500-mg amount to £2.64 ± 0.57 (€3.53 ± 0.77) per gram for 1 kg. The published cases and Internet user reports suggest the acute effects of ethylphenidate are similar to other stimulant drugs; the most common route of use was by nasal insufflation. The most common desired effects were euphoria, stimulation, and increased concentration, sociability, and energy levels; the most common unwanted effects included anxiety, palpitations, insomnia, and paranoia.
CONCLUSION: This review of the scientific and grey literature has demonstrated that the acute harms associated with its use are stimulant in nature and that ethylphenidate is widely available to users over the Internet, with significant discounts for bulk purchases.

Entities:  

Keywords:  Ethylphenidate; Novel psychoactive substance; Recreational drug; Toxicity

Mesh:

Substances:

Year:  2015        PMID: 26195274     DOI: 10.1007/s00228-015-1906-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  36 in total

Review 1.  What should we do about student use of cognitive enhancers? An analysis of current evidence.

Authors:  C Ian Ragan; Imre Bard; Ilina Singh
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

Review 2.  Circadian clock genes: effects on dopamine, reward and addiction.

Authors:  Puja K Parekh; Angela R Ozburn; Colleen A McClung
Journal:  Alcohol       Date:  2015-01-08       Impact factor: 2.405

Review 3.  New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder.

Authors:  Kennerly S Patrick; Mario A González; Arthur B Straughn; John S Markowitz
Journal:  Expert Opin Drug Deliv       Date:  2005-01       Impact factor: 6.648

4.  Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity.

Authors:  Robin L Williard; Lawrence D Middaugh; Hao-Jie B Zhu; Kennerly S Patrick
Journal:  Behav Pharmacol       Date:  2007-02       Impact factor: 2.293

5.  Single and multiple dose pharmacokinetics of etizolam in healthy subjects.

Authors:  C Fracasso; S Confalonieri; S Garattini; S Caccia
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Carboxylesterase-mediated transesterification of meperidine (Demerol) and methylphenidate (Ritalin) in the presence of [2H6]ethanol: preliminary in vitro findings using a rat liver preparation.

Authors:  J A Bourland; D K Martin; M Mayersohn
Journal:  J Pharm Sci       Date:  1997-12       Impact factor: 3.534

7.  Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans.

Authors:  Kennerly S Patrick; Arthur B Straughn; Owen T Reeves; Hilary Bernstein; Guinevere H Bell; Erica R Anderson; Robert J Malcolm
Journal:  Drug Metab Dispos       Date:  2012-10-25       Impact factor: 3.922

Review 8.  Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.

Authors:  Kennerly S Patrick; Timothy R Corbin; Cristina E Murphy
Journal:  J Pharm Sci       Date:  2014-10-09       Impact factor: 3.534

9.  Interactive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J mice.

Authors:  William C Griffin; Robin W McGovern; Guinevere H Bell; Patrick K Randall; Lawrence D Middaugh; Kennerly S Patrick
Journal:  Psychopharmacology (Berl)       Date:  2012-09-07       Impact factor: 4.530

10.  Methoxetamine (MXE)--a phenomenological study of experiences induced by a "legal high" from the internet.

Authors:  Anette Kjellgren; Kristoffer Jonsson
Journal:  J Psychoactive Drugs       Date:  2013 Jul-Aug
View more
  4 in total

1.  Repeated Use of the Psychoactive Substance Ethylphenidate Impacts Neurochemistry and Reward Learning in Adolescent Male and Female Mice.

Authors:  Meridith T Robins; Arryn T Blaine; Jiwon E Ha; Amy L Brewster; Richard M van Rijn
Journal:  Front Neurosci       Date:  2019-02-19       Impact factor: 4.677

2.  Characteristics of NPS use in patients admitted to acute psychiatric services in Southeast Scotland: a retrospective cross-sectional analysis following public health interventions.

Authors:  Kyle H Bennett; Helen M Hare; Robert M Waller; Helen L Alderson; Stephen Lawrie
Journal:  BMJ Open       Date:  2017-12-03       Impact factor: 2.692

Review 3.  Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability.

Authors:  Christopher N Floyd; David M Wood; Paul I Dargan
Journal:  Eur J Clin Pharmacol       Date:  2017-12-03       Impact factor: 2.953

Review 4.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.